Monteris Mecical scores regulatory wins in the U.S. and in Canada, also touting positive clinical trial results for the NeuroBlate MRI-guided brain tumor treatment system.

Monteris Medical won a regulatory nod in the U.S. and in Canada for its NeuroBlate MRI-guided tumor ablation device, the company said.

Monteris calls NeuroBlate a tumor “cooker” which uses an MRI-guided laser system to heat and kill brain tumors. Positive results in the 1st-in-human trials were published earlier this month in the Journal of Neurosurgery.